Shifting blame: Buprenorphine prescribers, addiction treatment, and prescription monitoring in middle-class America

Sonia Mendoza, Allyssa S. Rivera-Cabrero, Helena Hansen

    Research output: Contribution to journalArticle

    Abstract

    Growing nonmedical prescription opioid analgesic use among suburban and rural Whites has changed the public's perception of the nature of opioid addiction, and of appropriate interventions. Opioid addiction has been recast as a biological disorder in which patients are victims of their neurotransmitters and opioid prescribers are irresponsible purveyors of dangerous substances requiring controls. This framing has led to a different set of policy responses than the "War on Drugs" that has focused on heroin trade in poor urban communities; in response to prescription opioid addiction, prescription drug monitoring programs and tamper-resistant opioid formulations have arisen as primary interventions in place of law enforcement. Through the analysis of preliminary findings from interviews with physicians who are certified to manage opioid addiction with the opioid pharmaceutical buprenorphine, we argue that an increase in prescriber monitoring has shifted the focus from addicted people to prescribers as a threat, paradoxically driving users to illicit markets and constricting their access to pharmaceutical treatment for opioid addiction. Prescriber monitoring is also altering clinical cultures of care, as general physicians respond to heightened surveillance and the psychosocial complexities of treating addiction with either rejection of opioid dependent patients, or with resourceful attempts to create support systems for their treatment where none exists.

    Original languageEnglish (US)
    Pages (from-to)465-487
    Number of pages23
    JournalTranscultural Psychiatry
    Volume53
    Issue number4
    DOIs
    StatePublished - Aug 1 2016

    Fingerprint

    Buprenorphine
    addiction
    Opioid Analgesics
    middle class
    Prescriptions
    medication
    monitoring
    pharmaceutical
    Therapeutics
    physician
    drug
    law enforcement
    surveillance
    Pharmaceutical Preparations
    Physicians
    Law Enforcement
    Prescription Drugs
    threat
    Drug Monitoring
    Heroin

    Keywords

    • buprenorphine
    • opioid maintenance treatment
    • prescription monitoring programs

    ASJC Scopus subject areas

    • Health(social science)
    • Psychiatry and Mental health

    Cite this

    Shifting blame : Buprenorphine prescribers, addiction treatment, and prescription monitoring in middle-class America. / Mendoza, Sonia; Rivera-Cabrero, Allyssa S.; Hansen, Helena.

    In: Transcultural Psychiatry, Vol. 53, No. 4, 01.08.2016, p. 465-487.

    Research output: Contribution to journalArticle

    Mendoza, Sonia ; Rivera-Cabrero, Allyssa S. ; Hansen, Helena. / Shifting blame : Buprenorphine prescribers, addiction treatment, and prescription monitoring in middle-class America. In: Transcultural Psychiatry. 2016 ; Vol. 53, No. 4. pp. 465-487.
    @article{a1b9f2f6a7454474aaff1fcd7bb33dd3,
    title = "Shifting blame: Buprenorphine prescribers, addiction treatment, and prescription monitoring in middle-class America",
    abstract = "Growing nonmedical prescription opioid analgesic use among suburban and rural Whites has changed the public's perception of the nature of opioid addiction, and of appropriate interventions. Opioid addiction has been recast as a biological disorder in which patients are victims of their neurotransmitters and opioid prescribers are irresponsible purveyors of dangerous substances requiring controls. This framing has led to a different set of policy responses than the {"}War on Drugs{"} that has focused on heroin trade in poor urban communities; in response to prescription opioid addiction, prescription drug monitoring programs and tamper-resistant opioid formulations have arisen as primary interventions in place of law enforcement. Through the analysis of preliminary findings from interviews with physicians who are certified to manage opioid addiction with the opioid pharmaceutical buprenorphine, we argue that an increase in prescriber monitoring has shifted the focus from addicted people to prescribers as a threat, paradoxically driving users to illicit markets and constricting their access to pharmaceutical treatment for opioid addiction. Prescriber monitoring is also altering clinical cultures of care, as general physicians respond to heightened surveillance and the psychosocial complexities of treating addiction with either rejection of opioid dependent patients, or with resourceful attempts to create support systems for their treatment where none exists.",
    keywords = "buprenorphine, opioid maintenance treatment, prescription monitoring programs",
    author = "Sonia Mendoza and Rivera-Cabrero, {Allyssa S.} and Helena Hansen",
    year = "2016",
    month = "8",
    day = "1",
    doi = "10.1177/1363461516660884",
    language = "English (US)",
    volume = "53",
    pages = "465--487",
    journal = "Transcultural Psychiatry",
    issn = "1363-4615",
    publisher = "SAGE Publications Ltd",
    number = "4",

    }

    TY - JOUR

    T1 - Shifting blame

    T2 - Buprenorphine prescribers, addiction treatment, and prescription monitoring in middle-class America

    AU - Mendoza, Sonia

    AU - Rivera-Cabrero, Allyssa S.

    AU - Hansen, Helena

    PY - 2016/8/1

    Y1 - 2016/8/1

    N2 - Growing nonmedical prescription opioid analgesic use among suburban and rural Whites has changed the public's perception of the nature of opioid addiction, and of appropriate interventions. Opioid addiction has been recast as a biological disorder in which patients are victims of their neurotransmitters and opioid prescribers are irresponsible purveyors of dangerous substances requiring controls. This framing has led to a different set of policy responses than the "War on Drugs" that has focused on heroin trade in poor urban communities; in response to prescription opioid addiction, prescription drug monitoring programs and tamper-resistant opioid formulations have arisen as primary interventions in place of law enforcement. Through the analysis of preliminary findings from interviews with physicians who are certified to manage opioid addiction with the opioid pharmaceutical buprenorphine, we argue that an increase in prescriber monitoring has shifted the focus from addicted people to prescribers as a threat, paradoxically driving users to illicit markets and constricting their access to pharmaceutical treatment for opioid addiction. Prescriber monitoring is also altering clinical cultures of care, as general physicians respond to heightened surveillance and the psychosocial complexities of treating addiction with either rejection of opioid dependent patients, or with resourceful attempts to create support systems for their treatment where none exists.

    AB - Growing nonmedical prescription opioid analgesic use among suburban and rural Whites has changed the public's perception of the nature of opioid addiction, and of appropriate interventions. Opioid addiction has been recast as a biological disorder in which patients are victims of their neurotransmitters and opioid prescribers are irresponsible purveyors of dangerous substances requiring controls. This framing has led to a different set of policy responses than the "War on Drugs" that has focused on heroin trade in poor urban communities; in response to prescription opioid addiction, prescription drug monitoring programs and tamper-resistant opioid formulations have arisen as primary interventions in place of law enforcement. Through the analysis of preliminary findings from interviews with physicians who are certified to manage opioid addiction with the opioid pharmaceutical buprenorphine, we argue that an increase in prescriber monitoring has shifted the focus from addicted people to prescribers as a threat, paradoxically driving users to illicit markets and constricting their access to pharmaceutical treatment for opioid addiction. Prescriber monitoring is also altering clinical cultures of care, as general physicians respond to heightened surveillance and the psychosocial complexities of treating addiction with either rejection of opioid dependent patients, or with resourceful attempts to create support systems for their treatment where none exists.

    KW - buprenorphine

    KW - opioid maintenance treatment

    KW - prescription monitoring programs

    UR - http://www.scopus.com/inward/record.url?scp=84985010330&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84985010330&partnerID=8YFLogxK

    U2 - 10.1177/1363461516660884

    DO - 10.1177/1363461516660884

    M3 - Article

    VL - 53

    SP - 465

    EP - 487

    JO - Transcultural Psychiatry

    JF - Transcultural Psychiatry

    SN - 1363-4615

    IS - 4

    ER -